ASP Isotopes (NASDAQ:ASPI) COO Sells $47,475.00 in Stock

ASP Isotopes Inc. (NASDAQ:ASPI) COO Robert Ainscow sold 22,500 shares of the business’s stock in a transaction on Wednesday, October 14th. The stock was sold at an average price of $2.11, for a total value of $47,475.00. Following the completion of the transaction, the chief operating officer owned 2,225,941 shares of the company’s stock, valued at $4,696,735.51. This represents a 1.00% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Robert Ainscow also recently made the following trade(s):

• On Tuesday, September 8th, Robert Ainscow sold 8,438 shares of ASP Isotopes stock. The shares were sold at an average price of $4.29, for a total value of $36,199.02.
• On Wednesday, September 2nd, Robert Ainscow sold 25,000 shares of ASP Isotopes stock. The shares were sold at an average price of $3.90, for a total value of $97,500.00.

ASP Isotopes Price Performance

NASDAQ ASPI opened at $2.17 on Thursday. ASP Isotopes Inc. has a one year low of $1.89 and a one year high of $11.22. The stock has a 50-day moving average of $3.26 and a 200 day moving average of $4.68. The company has a market capitalization of $332.68 million, a price-to-earnings ratio of -1.64 and a beta of 3.69. The company has a debt-to-equity ratio of 0.76, a quick ratio of 3.85 and a current ratio of 3.87.

ASP Isotopes (NASDAQ:ASPI) last issued its earnings results on Friday, August 14th. The company reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.11). The business had revenue of $5.12 million during the quarter, compared to analysts’ expectations of $4.47 million. ASP Isotopes had a negative return on equity of 64.99% and a negative net margin of 427.98%.

Hedge Funds Weigh In On ASP Isotopes

Institutional investors have recently bought and sold shares of the stock. Bank of America Corp DE bought a new stake in ASP Isotopes during the second quarter valued at about $4,410,000. BlackRock Inc. purchased a new stake in ASP Isotopes in the second quarter worth about $57,331,000. Bank of New York Mellon Corp purchased a new stake in ASP Isotopes in the second quarter worth about $2,220,000. Man Group plc bought a new position in shares of ASP Isotopes in the second quarter worth about $5,153,000. Finally, AWM Investment Company Inc. bought a new position in shares of ASP Isotopes in the second quarter worth about $9,837,000. 16.80% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

ASPI has been the subject of a number of research reports. Wall Street Zen upgraded shares of ASP Isotopes from a “strong sell” rating to a “sell” rating in a research note on Saturday, August 22nd. Weiss Ratings reissued a “sell (d-)” rating on shares of ASP Isotopes in a report on Monday, September 21st. Two analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, ASP Isotopes has an average rating of “Hold” and a consensus target price of $13.00.

About ASP Isotopes

ASP Isotopes Inc (NASDAQ: ASPI) is a development-stage advanced materials company focused on isotope enrichment. The company is developing proprietary technology intended to separate and enrich isotopes for use in several high-value markets, including nuclear energy, medicine, semiconductors, quantum computing and other industrial applications.

ASP Isotopes has described its platform as being designed to provide more efficient and scalable isotope production than certain conventional enrichment methods.